CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6978 result(s)

Infliximab (Remicade)

Last Updated: September 29, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Infliximab
Indications: Ulcerative Colitis

  • Brand Name: Remicade
  • Manufacturer: Centocor Inc.
  • Project Number: S0146
  • Project Status: Complete
  • Submission Type: New